Evidence map›Paper›PMID 26184153›Full record

ArticleMolecules (Basel, Switzerland)2015

7-Epiclusianone, a Benzophenone Extracted from Garcinia brasiliensis (Clusiaceae), Induces Cell Cycle Arrest in G1/S Transition in A549 Cells.

Marisa Ionta, Guilherme A Ferreira-Silva, Evandro L Niero, Éderson D'Martin Costa, Adam A Martens, Welton Rosa, Marisi G Soares, Gláucia M Machado-Santelli, João Henrique G Lago, Marcelo H Santos

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  3. 7-Molecules (Basel, Switzerland) · 2019
    Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Marisa IontaInstitute of Biomedical Sciences, Federal University of Alfenas, 37130-000 Alfenas, Brazil. marisaionta@gmail.com.
Guilherme A Ferreira-SilvaInstitute of Biomedical Sciences, Federal University of Alfenas, 37130-000 Alfenas, Brazil. alfer_gui@hotmail.com.
Evandro L NieroDepartment of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, 05508-000 São Paulo, Brazil. eloniero@yahoo.com.
Éderson D'Martin CostaInstitute of Chemistry, Federal University of Alfenas, 37130-000 Alfenas, Brazil.
Adam A MartensDepartment of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, 05508-000 São Paulo, Brazil. adam.arai@gmail.com.
Welton RosaInstitute of Chemistry, Federal University of Alfenas, 37130-000 Alfenas, Brazil. welton_rosa@hotmail.com.
Marisi G SoaresInstitute of Chemistry, Federal University of Alfenas, 37130-000 Alfenas, Brazil. marisigs@gmail.com.
Gláucia M Machado-SantelliDepartment of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, 05508-000 São Paulo, Brazil.
João Henrique G LagoInstitute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of Sao Paulo, 09920-000 Diadema, Brazil. joao.lago@unifesp.br.
Marcelo H SantosInstitute of Chemistry, Federal University of Viçosa, 36570-900 Viçosa, Brazil. marcelo_hs@yahoo.com.br.
Universidade Federal de Alfenas · BRUniversidade de São Paulo · BRUniversidade Federal de São Paulo · BRUniversidade Federal de Viçosa · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is the leading cause of cancer deaths in the world. Disease stage is the most relevant factor influencing mortality. Unfortunately, most patients are still diagnosed at an advanced stage and their five-year survival rate is only 4%. Thus, it is relevant to identify novel drugs that can improve the treatment options for lung cancer. Natural products have been an important source for the discovery of new compounds with pharmacological potential including antineoplastic agents. We have previously isolated a prenylated benzophenone (7-epiclusianone) from Garcinia brasiliensis (Clusiaceae) that has several biological properties including antiproliferative activity against cancer cell lines. In continuation with our studies, the present work aimed to investigate the mechanisms involved with antiproliferative activity of 7-epiclusianone in A549 cells. Our data showed that 7-epiclusianone reduced the viability of A549 cells in a concentration-dependent manner (IC50 of 16.13 ± 1.12 μM). Cells were arrested in G1/S transition and apoptosis was induced. In addition, we observed morphological changes with cytoskeleton disorganization in consequence of the treatment. Taken together, the results showed that cell cycle arrest in G1/S transition is the main mechanism involved with antiproliferative activity of 7-epiclusianone. Our results are promising and open up the prospect of using this compound in further anticancer in vivo studies.

Indexed as

Antineoplastic Agents, PhytogenicApoptosisBenzophenonesBenzoquinonesCell Line, TumorCell SurvivalCytoskeletonEpithelial CellsFruitG1 Phase Cell Cycle CheckpointsGarciniaHumansPlant ExtractsRespiratory Mucosa7-epiclusianoneAntineoplastic Agents, PhytogenicBenzophenonesBenzoquinonesPlant Extracts7-epiclusianoneantiproliferative activitycell cycle arrestcell deathGarcinia brasiliensislung cancer

Identifiers

PMID26184153
PMCPMC6332126
OpenAlexW1572712581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.